Filing Details
- Accession Number:
- 0001127602-25-017593
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-16 19:26:03
- Reporting Period:
- 2025-06-12
- Filing Date:
- 2025-06-16
- Accepted Time:
- 2025-06-16 19:26:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1758108 | Ellen Feigal | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | Yes | No | No | No |
Transaction Summary
| Sold: | 2,993 shares | Avg. Price: $9.22 | Total Value: $27,595.46 |
| Number of Shares After Transactions: | 19,183 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-12 | 13,686 | $0.00 | 22,176 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-06-16 | 2,993 | $9.22 | 19,183 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2025-06-12 | 27,372 | $0.00 | 27,372 | $9.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,372 | 2035-06-11 | No | 4 | A | Direct |
Footnotes
- Represents restricted stock units that shall fully vest on the first anniversary of the date of grant.
- This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024.
- The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 12, 2025, such that the total number of shares will be fully vested on June 12, 2026.
Billionaire Hedge Funds
